Atlas Trials

A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma

Clinical trial NCT06717113 · RECRUITING

Trial details

NCT number
NCT06717113
Sponsor
Peking University First Hospital
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma and Malignant Plasma Cell Neoplasms
Start date
2025-04-15
Primary completion
2025-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.